作者:Shilpi Mittal、Alpeshkumar Malde、C. Selvam、K.H.S. Arun、P.S. Johar、Sanjay M. Jachak、P. Ramarao、P.V. Bharatam、H.P.S. Chawla
DOI:10.1016/j.bmcl.2003.11.066
日期:2004.2
Herein we report an efficient procedure to synthesize S-4-(3-thienyl)phenyl-alpha-methylacetic acid, an enantiomerically pure intermediate of a recently approved nonsteroidal antiinflammatory cyclooxygenase inhibitor, atliprofen [methyl RS-4-(3-thienyl)phenyl-alpha-methylacetate]. The interactions of the active S-isomer of the acid were theoretically compared with those of S-ibuprofen through molecular docking studies using COX-1 and COX-2 protein structures. The results were corroborated by in vitro and in vivo studies. (C) 2003 Elsevier Ltd. All rights reserved.